Startup India Government of India
Nephropro DMSS Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.5 Cr
▲ 14% YoY
Net profit · FY 2025
₹11.15 Lakh
Net margin 7.4%
EBITDA · FY 2025
₹23.99 Lakh
EBITDA margin 16%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹49.24 Lakh
No open charges
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Nephropro DMSS Private Limited
Data last updated:
Nephropro DMSS Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the renal care and dialysis clinics segment of the healthcare sector. It was incorporated on 13 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2020PTC139223.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Reena Adiraju and Sairam Adiraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #1 – 4 – 211/Hu/68 Prathmapuri Colony Sainkpuri, Hyderabad, Telangana, India – 500062.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.5 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹11.15 Lakh (net margin 7.4%) and EBITDA of ₹23.99 Lakh (EBITDA margin 16%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
As per MCA filings, the company has satisfied charges of ₹49.24 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
Nephropro DMSS Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0009912). For more details, the company can be reached via its website nephropro.com.
Company details
CIN U85100TG2020PTC139223
Registration Number 139223
Incorporation Date 13 February 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0009912
Key People
Reena Adiraju Director Sairam Adiraju Director Recognitions & Rankings of Nephropro DMSS
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0009912
Contact details
Nephropro DMSS Private Limited's registered office is in Hyderabad, Telangana. Its website is nephropro.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address#1 – 4 – 211/Hu/68 Prathmapuri Colony Sainkpuri, Hyderabad, Telangana, India – 500062
- IndustryHealthcare, Renal Care & Dialysis Clinics
To see the full contact details of Nephropro DMSS Private Limited, buy the company report.
Comprehensive company report
Nephropro DMSS Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nephropro DMSS is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Nephropro DMSS Private Limited, buy the company report.
Financials of Nephropro DMSS Private Limited
FY 2025 filings availableNephropro DMSS Private Limited reported revenue of ₹1.5 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹1.5 Cr ▲ 14%
Net profit · FY 2025
₹11.15 Lakh margin 7.4%
EBITDA · FY 2025
₹23.99 Lakh margin 16%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 1%
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 14% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | ||||
| Net Profit Margin | 7.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nephropro DMSS Private Limited, buy the company report.
Board of directors of Nephropro DMSS Private Limited
Nephropro DMSS has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Reena Adiraju | Director | 13 Feb 2020 | 6 Years 8 Months | Current |
| Sairam Adiraju | Director | 13 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Nephropro DMSS Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Renal Care), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Balaji Institute of Renal Diseases Private Limited | ₹2.7 Cr (FY 2025) | 58.0% | Allahabad, Uttar Pradesh, India | |||
| Nephropro DMSS Private Limitedthis company | ₹1.5 Cr (FY 2025) | ₹11.15 Lakh | 7.4% | 14.0% | Hyderabad, Telangana, India | |
| Tamil Nadu Urological Research Centre Private Limited | ₹1.45 Cr (FY 2025) | -15.0% | Chennai, Tamil Nadu, India | |||
| Gursewa Dialysis India Limited | ₹83.8 Lakh (FY 2024) | 18.0% | New Delhi, Delhi, India | |||
| Crest Clinical Services Private Limited | ₹75.24 Lakh (FY 2025) | -7.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Nephropro DMSS Private Limited, buy the company report.
Auditor
Nephropro DMSS Private Limited is audited by RAJU & SRINIVAS for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJU & SRINIVAS | FY 2021 | 007184S |
Shareholding
The shareholding of Nephropro DMSS Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nephropro DMSS Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹49.24 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jun 2021 | 100458399 | Axis Bank Limited | ₹32.58 Lakh | Satisfied | |
| 16 Mar 2021 | 100436007 | Hdfc Bank Limited | ₹16.66 Lakh | Satisfied |
To see the full charge records of Nephropro DMSS Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Nephropro DMSS Private Limited has 1 court case on record: 1 filed by Nephropro DMSS. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against The State of Telangana | Disposed |
To see the full case history of Nephropro DMSS Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nephropro DMSS Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nephropro DMSS Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nephropro DMSS Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Reena Adiraju was appointed as Director on 13 Feb 2020.
AGM
Nephropro Dmss Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nephropro Dmss Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 18 Jun 2021 via Charge ID 100458399 with Axis Bank Limited was fully satisfied on 19 Oct 2024.
Charges
A charge registered on 16 Mar 2021 via Charge ID 100436007 with Hdfc Bank Limited was fully satisfied on 07 Mar 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 32.58 Lakh with Charge ID 100458399 was registered on 18 Jun 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.66 Lakh with Charge ID 100436007 was registered on 16 Mar 2021.
Appointed
Reena Adiraju was appointed as Director.
Appointed
Sairam Adiraju was appointed as Director.
Incorporation
13 Feb 2020
Nephropro Dmss Private Limited was registered on 13 Feb 2020 with Roc Hyderabad & aged 6 years 8 months as per MCA records.
Frequently asked questions
Nephropro DMSS is an active private limited company based in Hyderabad, Telangana, India. The company works in renal care and dialysis clinics, within the healthcare industry. It was incorporated on 13 February 2020 (6+ years old) and is registered under CIN U85100TG2020PTC139223.
Nephropro DMSS has 2 current directors:
- Reena Adiraju - Director
- Sairam Adiraju - Director
The latest financial statements of Nephropro DMSS on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Nephropro DMSS is U85100TG2020PTC139223. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nephropro DMSS has 1 court case on record: 1 filed by the company.
Nephropro DMSS was incorporated on 13 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nephropro DMSS by revenue are Balaji Institute of Renal Diseases Private Limited, Tamil Nadu Urological Research Centre Private Limited, Gursewa Dialysis India Limited, Crest Clinical Services Private Limited, all in the Healthcare industry (Renal Care), with the same principal business activity (other hospital and medical care activities).
Reena Adiraju was appointed as Director on 13 Feb 2020. Sairam Adiraju was appointed as Director on 13 Feb 2020.
Yes, Nephropro DMSS is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Nephropro DMSS is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0009912).
Nephropro DMSS can be reached through the website nephropro.com. Its registered office is in Hyderabad, Telangana, India.